Intercept Pharmaceuticals to Conduct Fireside Chats and One-on-One Meetings at Upcoming Investor Conferences
H.C. Wainwright25th Annual Global Investment Conference, for which the chat will be taking place on September 11th, 2023, from 11:00-11:30am ET. The Baird Global Healthcare Conference, for which the chat will be taking place on September 13th, 2023, from 3:10-3:40pm ET.
The fireside chats can be accessed on the investor page of Intercept’s website at http://ir.interceptpharma.com.
Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare and serious liver diseases, including primary biliary cholangitis (PBC) and severe alcohol-associated hepatitis (sAH). For more information, please visit www.interceptpharma.com or connect with the Company on LinkedIn, Threads, and X (formerly Twitter).
For more information about Intercept, please contact:
Source: Intercept Pharmaceuticals, Inc.